drugset / Trial / NCT00515619
Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this trial is to determine safety and efficacy of Lacosamide under long term therapy.
Timeline
- Start
- 2004-12
- Primary completion
- 2010-08
- Completion
- 2010-08
Publications
- Results Borghs S, de la Loge C, Brabant Y, Cramer J. Sensitivity testing of the Seizure Severity Questionnaire (SSQ). Epilepsy Behav. 2014 Feb;31:281-5. doi: 10.1016/j.yebeh.2013.10.010. Epub 2013 Nov 22.
- Rosenow F, Kelemen A, Ben-Menachem E, McShea C, Isojarvi J, Doty P; SP774 study investigators. Long-term adjunctive lacosamide treatment in patients with partial-onset seizures. Acta Neurol Scand. 2016 Feb;133(2):136-144. doi: 10.1111/ane.12451. Epub 2015 Jul 2.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lacosamide | Other / unclassified | 100 mg | Oral |
| Subject | Lacosamide | Other / unclassified | 800 mg | Oral |